Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data QUANTUM CORP /DE/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
493
438
403
403
350
383
422
312
274
280
Cost of revenue
288
265
235
230
199
226
279
187
164
177
Gross profit
205
173
168
173
151
158
143
125
110
103
Research and development
44.4
38.6
32.1
36.3
41.7
51.8
44.6
38
31.1
23.5
Selling and marketing
101
102
69.4
59.5
54.9
63
66
60.9
52.3
52
General and administrative
51.6
52.1
65.3
54.5
42
45.3
47.8
51.5
64
43.9
Operating expenses
199
201
172
151
142
161
160
154
152
128
Operating income
6.68
-28.6
-4.75
21.2
8.4
-3.24
-16.7
-28.9
-41.7
-24.5
Interest expense
7.99
11.7
21.1
25.4
27.5
11.9
10.6
15.1
23.6
21.6
Other non-operating income
-0.6
0.77
2.88
-0.26
-1.31
-0.25
1.96
-1.75
-0.71
-1.51
Pre-tax income
-0.75
-46.5
-40.4
-4.41
-35.2
39.7
-16.4
-40.6
-114
-100
Income tax
1.66
-3.11
2.38
0.8
0.24
1.34
1.94
0.71
0.82
1.01
Net income
-2.41
-43.3
-42.8
-5.21
-35.5
38.4
-18.4
-41.3
-115
-101
EBITDA
12.3
-23.7
-0.48
25.5
14.1
6.18
-6.56
-19.6
-36.1
-19.2
EPS, basic
-0.82
-14.68
-14.09
-1.64
-9.75
13.12
-4.04
-8.68
-22.35
-7.97
EPS, diluted
-0.82
-14.68
-14.09
-1.64
-9.75
-6.46
-5.65
-8.68
-22.35
-7.97
Shares, basic (weighted)
2.87
2.95
3.03
3.2
3.65
2.92
4.48
4.75
5.15
12.7
Shares, diluted (weighted)
2.87
2.95
3.03
3.2
3.65
3.27
4.52
4.75
5.15
12.7
Balance sheet
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
13
10.9
10.8
6.44
27.4
5.21
26
25.7
16.5
15.6
Receivables
102
96.4
86.8
70.4
73.1
69.4
72.5
67.8
52.5
69.7
Inventory
15.1
22.1
11.5
16.3
12.7
14.6
6.96
7.07
22.4
16.1
Other current assets
9.18
13.6
18.1
8.49
3.05
4.7
5.51
8.41
8.53
8.07
Total current assets
183
178
154
136
156
145
153
132
103
112
Property, plant and equipment
10.9
9.7
8.44
9.05
10.1
12.9
16.6
12
11.4
9.28
Lease right-of-use assets
0
12.7
9.38
11.1
10.3
9.43
8.58
7.42
Goodwill
0
3.47
13
13
13
13
13
Intangible assets
0.28
0.14
0.03
0
5.04
9.58
4.94
1.67
0.28
0
Other non-current assets
6.93
9.5
5.15
3.43
5.92
9.93
15.8
19.7
19.4
14.7
Total assets
221
203
173
166
195
202
214
188
155
157
Accounts payable
40.8
62.6
37.4
36.9
35.2
34.2
35.7
26.1
31.5
29.3
Accrued liabilities
15.9
17.6
29
17.5
18.8
16.6
13.7
14
18
19.5
Deferred revenue
92.3
96.9
90.4
81.5
84
87.1
79.8
78.5
75.1
75.7
Short-term debt
7.5
1.65
7.32
1.85
4.38
5
82.5
96.5
54.8
Total current liabilities
238
207
178
158
159
177
158
250
258
206
Long-term debt
66.7
116
146
147
89.4
66.4
0
Lease liabilities
0
10.8
8.01
9.89
10.2
9.62
8.93
8.17
Other non-current liabilities
13
11.6
11.8
11.2
13.1
11.8
11.4
11.4
14.4
12.7
Total liabilities
361
376
373
365
307
345
298
309
320
356
Total debt
65
116
146
147
90.9
107
83.1
0
0
90
Paid-in capital
474
482
499
506
627
625
702
708
780
854
Retained earnings
-612
-655
-698
-703
-739
-768
-786
-827
-942
-1,044
Other comprehensive income
-1.68
-0.27
-1.41
-1.52
-0.86
-1.42
-1.58
-2.19
-1.61
-9.46
Shareholders' equity
-139
-173
-200
-199
-200
-144
-84.4
-121
-164
-199
Total equity
-139
-173
-200
-199
-200
-144
-84.4
-121
-164
-199
Total liabilities and equity
221
203
173
166
195
202
214
188
155
157
Shares outstanding
2.9
3.02
3.07
3.4
4.85
2.99
4.64
4.79
6.96
14.6
Cash flow statement
FY2017
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-2.41
-43.3
-42.8
-5.21
-35.5
38.4
-18.4
-41.3
-115
-101
Depreciation and amortization
5.64
4.97
4.27
4.29
5.7
9.42
10.1
9.31
5.6
5.28
Stock-based compensation
6.7
5.39
3.41
6.75
9.62
13.8
10.8
4.72
2.83
-0.85
Deferred income tax
0.18
0.14
1.46
-0.46
-0.77
-0.52
-0.18
-0.22
0.04
-0.32
Change in receivables
-0.37
6.51
8.05
15.2
-1.63
3.65
-2.97
4.85
15.2
-19.9
Change in inventory
0.8
0.94
Change in payables
-5.28
21.6
-25.4
-0.77
-1.99
-1.94
1.16
-11.2
6.15
-0.79
Cash from operations
8.56
-5.03
-16.9
-1.18
-0.77
-33.7
-4.89
-10.2
-23.6
-37.9
Capital expenditures
-2.22
-2.58
-2.71
-2.63
-6.93
-6.32
-12.6
-5.87
-4.95
-1.71
Acquisitions
0
0
0
-1.97
-2.66
-7.81
-3.02
0
Sales and maturities of investments
0.05
0.28
2.94
0
0
Cash from investing
-1.43
-2.3
0.24
-4.6
-9.59
-14.1
-15.6
-5.87
-4.95
-1.71
Debt issued
105
Stock issued
1.02
1.72
0
0
1.34
1.76
67.1
0
0
0.08
Cash from financing
-7.89
-11.2
16.2
1.21
31.3
20.2
41.2
15.7
19.3
39.2
Exchange rate effect
0.02
-0.15
0.06
-0.02
-0.11
0.05
0.01
-0
-0
0.03
Net change in cash
-0.75
-18.7
-0.35
-4.59
20.9
-27.6
20.7
-0.32
-9.26
-0.37
Free cash flow
6.34
-7.62
-19.6
-3.81
-7.7
-40
-17.5
-16
-28.6
-39.6
Interest paid
5.97
10.2
17.7
16.5
24.3
9.14
8.7
12.3
11.9
5.17
Income taxes paid
0.68
1.46
0.07
-0.49
-2.28
0.94
1.42
1.78
1.81
1.19
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $31.68 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
37.8%
Gross profit / revenue.
Operating margin
-2.3%
Operating income / revenue.
EBITDA margin
-0.5%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-80.3%
Pre-tax income / revenue.
Net margin
-80.8%
Net income / revenue.
FCF margin
-7.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-6.8%
Cash from operations / revenue.
Return on assets (ROA)
-124.6%
Net income / average total assets.
R&D / revenue
7.7%
Research and development expense / revenue.
Stock-based pay / revenue
0.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.3%
Capital expenditures / revenue.
D&A / revenue
1.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
2.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-12.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-4.4%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-6.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-10.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-7.3%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
1.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-9.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-4.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
146.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
41.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
28.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.93x
Current assets / current liabilities.
Quick ratio
0.76x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.34x
(Cash + short-term investments) / current liabilities.
Debt / assets
0.0%
Total debt / total assets.
Liabilities / assets
114.5%
Total liabilities / total assets.
Net debt
-$54.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$10.88
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$13.47
Revenue / diluted weighted shares.
FCF per share
-$0.95
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.91
Cash from operations / diluted weighted shares.
Book value per share
-$0.71
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
4.22x
Market cap / revenue.
EV/Sales
4.03x
Enterprise value / revenue.
FCF yield
-1.7%
Free cash flow / market cap.
Earnings yield
-19.2%
Net income / market cap (the inverse of P/E).
What was QUANTUM CORP /DE/'s revenue in fiscal 2026?
QUANTUM CORP /DE/ reported revenue of $279.6M for fiscal 2026, 2% higher than the year before.
Was QUANTUM CORP /DE/ profitable in fiscal 2026?
No. It reported a net loss of $101.0M.
How much free cash flow did QUANTUM CORP /DE/ generate in fiscal 2026?
Cash from operations of $37.9M minus capital expenditures of $1.7M left free cash flow of -$39.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.